Chairman Cooky Chen DVM

Mr. Chen received his M.S. degree in Veterinary Medicine from National Taiwan University and is an expert in the markets of domestic animals and companion animals. Mr. Chen oversees examinations of diseases in domestic animals, allergy detection in companion animals, development of product marketing plans for alternative therapy, and overall management of business operations. Mr. Chen also brings a wealth of experience in business planning and management to EBS.

Past experience
  • • Chief Manager, Merck Animal Health - Taiwan Branch (15 years)
    • Chief Advisor, Merck Animal Health - Taiwan Branch
    • Marketing Consultant, PRIT Biotech Co. Ltd. (a subsidiary of the Animal Technology Institute Taiwan)
    • Technical Consultant, U.S. IMRAB Biotech Co. in Asia
    • Technical Manager, CYC Co. Ltd. GMP Pharmaceuticals (Douliou plant construction)
    • Awarded the Li Zong-Dao Foundation Veterinarian Elite Award
    • Advisor, National Animal Poultry Health Center (deputy convener for 15 years)

Current positions
  • Director, Taipei Feed and Animal Drug Association (four consecutive terms)
  • Advisor, Taipei Veterinary Medical Association
    • Advisor, Taiwan Province Veterinary Medical Association
    • Advisor, Veterinarians of R.O.C. Federation
      • Board member, Taiwan University Veterinary Alumni Cultural Foundation (three consecutive terms)
Chair, Animal Health Foreign Businessman Club
COO  Tino Liu

Master of Human Resource Management, National Sun Yat-sen University

Bachelor of Department of Psychology, Fu Jen Catholic University


Expertise: Human Resources Management/Employee Training/TTQS (Taiwan Train Quality System) /Purchasing Process/General Affairs Management
Probation Assistant of Taiwan Taipei District Court
2013~NOW EBS
2016~201708 Human Resources Manager & Administration Director
201709~ Vice Chief Operating Officer (Vice C.O.O.)

Expert John Chen Ph.D

Ph.D Biochemistry - University of Alberta, Edmonton, Alberta, Canada

Past experience

1997 - Present BioCheck, Inc.Foster City, CA 94404(Founder)
In 2014, BioCheck, Inc. was 100% acquired by OriGene Technologies, Inc.
1998 - 2002 Rapid Diagnostics, Inc.Burlingame, CA 94010(Cofounder)
In 2002, Rapid Diagnostics, Inc. was 100% acquired by ICN Pharmaceuticals
1983 - 1995 Medix Biotech, Inc.Foster City, CA 94404(Cofounder)
In 1992, Medix Biotech was 100% acquired by Genzyme Corporation
 1981 - 1990 Pacific Biotech, Inc.San Diego, CA 92121(Cofounder)
In 1990, Pacific Biotech, Inc. was 100% acquired by Eli Lily
1979 - 1981 Beckman Instruments Carlsbad, CA (Senior Development Chemist)
1977 - 1979 Mallinkrodt Corporation St. Louis, MO (Research Scientist)
1973 - 1975 Sigma Chemical Company St. Louis, MO(Chemist)
1973 - 1977 Research Fellow, Department of Medicine Washington University School of Medicine St. Louis, MO

Journal Articles
1. G. Schonfeld, R. A. Bradshaw, and J.S. Chen "Structure of High Density Lipoprotein. The Immunologic Reactivities of the Carboxyl and Amino Terminal Regions of Apolipoprotein A-I", J. Biol. Chem., 251:3921-3926 (1976).
2. G. Schonfeld, J.S. Chen and W.F. McDonnell, Ill, "Apo A-II Contents of Human Plasma High Density Lipoprotein Measured by Radioimmunoassay", Journal of Lipid Research, 18(5): 645-654 (1977).
3. G. Schonfeld, J.S. Chen and R.G. Roy, "Antigenic Properties of Apoproteins A-I and A-II in Intact High Density Lipoproteins", J. of Biol. Chem. 252 (19):66516654 (1977).
4. G. Schonfeld, J.S. Chen and R.G. Roy, "Use of Antibody Specificity to Study the Surface Disposition of Apoprotein A-I on Human High Density Lipoproteins", J. of Biol. Chem. 252   (1977).
5. GR. Warnick, C. Mayfield, J. Benderson, J.S. Chen and J.J. Albers, "HDLCholesterol Quantitation by Phosphotungstate-Mg2+ and by Dextran Sulfate-Mn2+-Polyethylene Glycol Precipitation, Both with Enzymic Cholesterol Assay Compared with the Lipid Research Method", American Journal of Clinical Pathology, 78:718-723 (1982).
6. C.Y. G. Lee, B. Whitman, J.S. Chen, A. Fung, and X. Lin, "Monoclonal AntibodyBased Immunoassays for Reliable Clinical Detection of Human Cardiac Troponin 1", Journal of Clinical Ligand Assay, 25:306-311 (2002).
7. J. Perk, 1. Gil-Bazo, Y. Chin, P. de Candia, J.S. Chen, Y. Zhao, S. Chao, W. Cheong, Y. Ke, H. Al-Ahmadie, W.L. Gerald, E. Brogi, and R. Benezra, "Reassessment of Idl Protein Expression in Human Mammary, Prostate, and Bladder Cancers Using a Monospecific Rabbit Monoclonal Anti-Idl Antibody", Cancer Res 66:10870-10877 (2006).
Expert Zurong Wu  Dr.
  Past experience

Master of Medicine, Shanghai Medical University


Expertise: rapid diagnostic kits development, production and clinical surgical
Affiliated Hospital of Kunming Medical University / Shanghai Fudan University Hospital - Surgeon, attending physician / lecturer (15 years)
University of California Medical Center Surgeon (Orthopedic) Visiting Physician / Fellow (3 years)
Applied Biotechnology, California, USA - Chemist / Product Supervisor (10 years)
California, USA ACON Lab-Scientist (3 years)
Alere, California, USA (7 years)
Chief Technology Officer, EBS.

Factory Sub-Chief Bue Chen

Master of Science in Medical Biotechnology and Laboratory Science, National Yang-Ming University, Taipei, Taiwan (09/2008~06/2010)


Certification and Licensure:

*Professional and Technical Qualification Screening Examinations for Registered
Medical Technologist
*Experienced in developing IVD products, process improvement, product troubleshooting, ISO 9001、ISO13485、GMP system
2010~NOW EBS
2010~ 2013 Researcher
2013~ 2015 Biotechnology Engineer
2016~ 2017 Production Manager
2017~ Factory Sub-Chief

Sales Director Hsin-Hui Hsieh
Past experience
  • Ms. Hsin-Hui Hsieh demonstrate in-depth understanding of probiotic product development, business analysis, production management and workflow design through job rotations.

Current positions
  • As the head of business unit, Hsin-Hui translate company strategy into clear objectives and use cross-department experience to support and assist team members in global business development.
Chief Veterinarian Jerry Chang DVM
Past experience
  • MSc of Veterinary Medicine, Graduate Institute of Molecular and Comparative Pathobiology, National Taiwan University, specializing in production medicine, swine clinical and pathological diagnosis, swine health management, batch production planning, biosecurity advisor/Audit.

Current positions
  • Jerry is a Chief Veterinarian of EBS livestock division. Responsible for the market development of livestock disease diagnostic products, as well as technical and consultant services for client.
R & D Director   Sophie Chen

Master of Basic Medical Sciences, Chang Gung University


Skill: Medical device regulation/ISO 13485 and Intellectual property management
Researcher of Formosa Biomedical Technology corp.
2010~NOW EBS
2010~2014 Senior Researcher & Regulatory Affair
2015~2016 Technical Director & R & D Deputy Director
2017~ R & D Director

R&D Dept. Yu-Chun Lee

Yu-Chun specializes in Virology, Immunology and Molecular biology. Furthermore, he has successfully supervised many programs of developing IVD.

Past experience
  • Researcher of EBS

    Director of Animal Reagents 


Current positions

As the director of R&D, Yu-Chun is responsible for designing and developing veterinary diagnostic products on the platforms of ELISA and lateral flow. 

QA and Clinical Laboratory Director Yiyin Kuo  MT

Master of Medical Biotechnology and Laboratory Science, Chang Gung University, 2010, Taoyuan.

Bachelor of Department of Medical Laboratory and Biotechnology, Chung Shan Medical University, 2008, Taichung.


Skill: immunology/ clinical experience of medical/ISO 13485 system integration/ technology/ GMP of IVD factory.

Accomplishment: The license of medical technologist/ Through the ISO17025 and ISO15189 regulations exam /ISO13485 Internal auditor/ maintain and update the GMP certificate.
2010~ 2012 Medical technologist at the Shuang Ho Hospital.
2012~NOW EBS
2012~ 2015 QA specialist
2015~ 2016 QA manager
2016/06~ 2016/11 QA Deputy Director
2016/11~ QA Director
2017/07~ QA Director and Clinical Laboratory Director

Finance Manager Sunny Weng
  Past experience

Sunny currently drives all the financial works for Initial Public Offerings, as well as internal control and audit.


Ms. Sunny Weng is well-experienced in finance management, specializes in integrating accounting and financial reports, implementing ERP system.

 B.S Lin Ph.D.



Ph.D. of Immunology, National Taiwan University College of Medicine


Expertise: molecular biology, cellular and molecular immunology
Post-Doctoral Fellow of Graduate Institute of Immunology, National Taiwan University, College of Medicine
Post-Doctoral Fellow of Genomics Research Center (GRC), Academia Sinica
Post-Doctoral Fellow of Research Center for Traditional Chinese Medicine (RCTCM), China Medical University Hospital

Senior Researcher Hayao Cheng Ph.D.



Ph.D. of Medicine, Kaohsiung Medical University.


Expertise in Recombined protein (antigen; antibody) development, monoclonal antibody development, antibody structure prediction, disease animal model development, transgenic animals and in vivo imaging.

Awards and Certification:
2008 and 2017 National Innovation Award.
2009 Program for Business Professionals-IPR Management Practice;
2015 Process Control for Patent Engineer certification of the Taiwan
Intellectual Property Training Academy.


Postdoctoral fellow, Center for Biomarkers and Biotech Drugs, Kaohsiung
Medical University
Postdoctoral fellow, Graduate Institute of Pharmacognosy, Taipei Medical
Awards and Certification:
2008 and 2017 National Innovation Award.
2009 Program for Business Professionals-IPR Management Practice;
2015 Process Control for Patent Engineer certification of the Taiwan
Intellectual Property Training Academy.